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Semaphorin 6A (Sema6A) (previously named Semaphorin VIa)
is the originally described member of the vertebrate sema-
phorin class 6, a group of transmembrane semaphorins homol-
ogous to the insect semaphorin class 1. Although Sema-1a
(previously named semaphorin I) has been implicated in axon
guidance in insects, the function of Sema6A is currently un-
known. We have expressed the extracellular domain of Sema6A
in mammalian cells as either a monomeric or a dimeric fusion
protein and tested for potential axon guidance effects on two
populations of embryonic neurons in growth cone collapse and
collagen matrix chemorepulsion assays. Sema6A was ob-
served to induce growth cone collapse of sympathetic neurons
with an EC50 of ;200 pM, although a 10-fold higher (EC50 of
;2 nM) concentration was necessary to induce growth cone
collapse of dorsal root ganglion neurons. The activity of
Sema6A is likely to depend on protein dimerization or oligomer-
ization. Although Sema6A mRNA is expressed in complex pat-
terns during embryonic development, it is strikingly absent from
sympathetic ganglia. Sema6A is, however, expressed in areas
avoided by sympathetic axons and in areas innervated by
sympathetics, but before their arrival. Our results demonstrate
that transmembrane semaphorins, like the secreted ones, can
act as repulsive axon guidance cues. Our findings are consis-
tent with a role for Sema6A in channeling sympathetic axons
into the sympathetic chains and controlling the temporal se-
quence of sympathetic target innervation.
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Developing axons are guided toward their target tissues by means
of their growth cones at the axon tips, which recognize and
respond to both attractive and repulsive guidance cues in the
environment along the axonal pathways (for review, see Tessier-
Lavigne and Goodman, 1996). Semaphorins are a large family,
including both secreted and membrane associated proteins, many
of which have been implicated as inhibitors or chemorepellents in
axon pathfinding, fasciculation and branching, and target selec-
tion (for review, see Mark et al., 1997). All semaphorins possess
an extracellular semaphorin (Sema) domain of ;500 amino acids
at the N terminus. Additional sequence motifs C terminal to the
semaphorin domain allow the semaphorins to be classified into
eight distinct subfamilies (Adams et al., 1996; Xu et al., 1998;
Semaphorin Nomenclature Committee, 1999; Yu and Kolodkin,
1999).
SEMA3A (collapsin-1–Sema III/D) is a member of class 3
vertebrate secreted semaphorins (Kolodkin et al., 1993; Luo et
al., 1993, 1995; Puschel et al., 1995). It is the best characterized
chemorepellent molecule in the semaphorin family and has been
implicated in the guidance of developing axons of the peripheral
nervous system and CNS. SEMA3A can induce the collapse of
sensory and sympathetic growth cones and can repel sensory and
sympathetic axons from a distance (Luo et al., 1993; Messersmith
et al., 1995; Puschel et al., 1995; Adams et al., 1997; Feiner et al.,
1997; Kobayashi et al., 1997; Koppel et al., 1997; Shepherd et al.,
1997; Chen et al., 1998; Takahashi et al., 1998). Targeted deletion
of Sema3A in mice resulted in defects in the patterning of sensory
and motor axon projections (Behar et al., 1996; Taniguchi et al.,
1997). Neuropilins have been shown to function as receptors or
components of receptor complexes for class 3 secreted semaphor-
ins (Chen et al., 1997; He and Tessier-Lavigne, 1997; Kolodkin et
al., 1998). In particular, neuropilin-1 was shown to be a receptor
for Sema3A. Mice lacking neuropilin-1 exhibit phenotypes simi-
lar to mice lacking Sema3A (Kitsukawa et al., 1997). Although
SEMA3A was shown to exhibit strong repulsive activity toward
sympathetic neurons, the structure of the sympathetic ganglion
chains in Sema3A null mice is only mildly defasciculated (Tani-
guchi et al., 1997). Many of the class 3 secreted semaphorins are
known to be repulsive toward sympathetic neurons (Adams et al.,
1997; Feiner et al., 1997; Chen et al., 1998; Giger et al., 1998;
Takahashi et al., 1998). It is possible that developing sympathetic
axons may be exposed to a number of semaphorins with redun-
dant inhibitory activity.
Although many members of class 3 secreted semaphorins have
been shown to be chemorepulsive toward selected populations of
embryonic neurons, it is not yet known whether vertebrate trans-
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membrane semaphorins function in a similar manner. In insects,
grasshopper Sema-1a (Semaphorin I), a transmembrane sema-
phorin with no obvious structural motifs following the Sema
domain (or Sema-PSI domain, as defined by Bork et al., 1999),
has been implicated in axon guidance. In vivo antibody blocking
experiments show that the G-Sema-1a is involved in the ventral
turn of Ti1 pioneer axons in the developing grasshopper limb bud
(Kolodkin et al., 1992). Recent experiments suggest that
G-Sema-1a could function as an attractive cue for the growth
cones of the subgenual organ (Wong et al., 1997). Drosophila
Sema-1a is closely related to G-Sema-1a. Genetic analysis sug-
gests that D-Sema-1a could function as a repulsive guidance cue
for embryonic motor axons (Yu et al., 1998). The repulsive
function of D-Sema-1a is likely to be mediated by its receptor
Drosophila Plexin A, which was shown to interact with D-Sema-1a
both genetically and biochemically (Winberg et al., 1998).
Sema6A is the first described member of class 6 vertebrate
transmembrane semaphorins that shares the same arrangement
of structural domains as found in the insect Sema-1a (Zhou et al.,
1997). The expression of Sema6A mRNA during embryonic
stages is regulated spatially and temporally in regions important
to nervous system development (Zhou et al., 1997). Since the
discovery of Sema6A, several other members of this class have
also been identified, yet the function of these semaphorins re-
mains primarily unknown (Eckhardt et al., 1997; Kikuchi et al.,
1997, 1999; L. Zhou, D. A. Fisher, F. A. White, and W. D. Snider,
unpublished results). Here, we show Sema6A to be an inhibitory
molecule active on embryonic sympathetic and sensory axons
in vitro and describe an expression pattern of this molecule
consistent with a role as a local inhibitor of developing sympa-
thetic axons in vivo.
MATERIALS AND METHODS
Expression constructs. Constructs for Sema6A protein expression in
mammalian cells were made as described previously (Xu et al., 1998).
Briefly, the extracellular domain of Sema6A cDNA was subcloned into
Myc-His-tagged and Fc-tagged expression vectors to create the con-
structs allowing the expression of C terminally tagged Myc-His or Fc
fusion proteins, Sema6A-mh and Sema6A-Fc, respectively. SEMA3A-Fc
and SEMA7A-Fc (previously named sema K1-Fc) expression constructs
were made and described previously (Xu et al., 1998).
Expression and purification of Sema6A fusion proteins. Stable 293-
EBNA cell lines secreting Myc-His-tagged or Fc-tagged Sema6A extra-
cellular domain were derived from transient transfection of the above
expression plasmids, followed by selection with G418. Conditioned media
from stably transfected cell lines were collected, and the protein produc-
tion and integrity were confirmed by Western blot using anti-Myc and
anti-Fc antibodies. The dimerization of the fusion proteins was assessed
by running samples in SDS-PAGE gel under reducing (sample buffer with
10% 2-mercaptoethanol) or nonreducing (sample buffer without 2-mercapto-
ethanol) conditions. For the purification of Sema6Aa-mh, conditioned
media from the Sema6A-mh-expressing cell line were collected, and
buffer was exchanged into Ni-NTA binding buffer (20 mM Tris, pH 7.5,
100 mM NaCl, 0.1% cholic acid, and 30 mM imidazole, pH 7.0). The
protein was bound to nickel Ni-NTA resin (Qiagen, Hilden, Germany)
and eluted with imidazole (150 mM in 20 mM Tris, pH 7.5, 100 mM NaCl,
and 1 mM EDTA, pH 5.0). For the purification of Sema6A-Fc, condi-
tioned media from the Sema6A-Fc-expressing cell line were collected,
and buffer was exchanged into Protein A Sepharose binding buffer (20
mM NaPO4, pH 7.0). The protein was bound to Protein A Sepharose
CL-4B resin (Amersham Pharmacia Biotech, Piscataway, NJ) and eluted
with 40 mM NaCitrate and 20 mM NaCl, pH 3.2. The protein concen-
trations of Sema6A-mh and Sema6A-Fc were estimated by comparing
the intensity of Coomassie blue stain in SDS-PAGE gel using BSA as
standard.
Growth cone collapse assay. Semaphorin fusion proteins were assayed
for growth cone collapsing activity on explanted chick embryonic day 7
(E7) dorsal root ganglia and E8 sympathetic chain ganglia as described
previously (Luo et al., 1993). Briefly, explants were dissected from chick
embryos and incubated in F12-based defined medium supplemented with
bovine pituitary extract and nerve growth factor (NGF) on eight-well
chamber slides precoated with poly-ornithine and mouse laminin. The
following day, purified semaphorin proteins, as described above, were
added to the explanted culture. After 1 hr incubation, the explants were
fixed in 4% paraformaldehyde at room temperature for 30 min. Explants
were then washed in PBS and stained with 3 U/ml rhodamine phalloidin
(Molecular Probes, Eugene, OR) in PBS at room temperature for 2 hr.
For mouse dorsal root ganglion (DRG) explants in which a significant
outgrowth of non-neuronal cells was present, axons were stained with
a monoclonal antibody to growth-associated protein 43 (GAP-43)
(2 mg/ml; Boehringer Mannheim, Indianapolis, IN). Growth cones were
visualized under fluorescence microscope (403) and scored as being
either normal or collapsed. The percentage of collapsed growth cones
was then plotted against the concentration of purified protein added to
the cultured explant. For experiments using mice, dorsal root or sympa-
thetic ganglia were dissected from E15 mouse embryos, and explants
were cultured as for chick.
Partially purified SEMA3A produced from baculovirus expression
system was used as a positive control in the dose–response study of
Sema6A-Fc activity. Human SEMA3A was engineered into the baculo-
virus transfer vector, pAcMP2 (PharMingen, San Diego, CA), and the
recombinant baculovirus capable of directing the expression of recom-
binant SEMA3A was produced. After 48 hr after infection, SEMA3A
protein was highly expressed in the culture media of Hi5 cells at 2–5 mg/ l
culture. The protein was enriched on an S-Sepharose cation exchange
column and was further purified through a Heparin–Sepharose column
to a purity of above 50%.
Chemorepulsion assay. Chemorepulsion assays were performed follow-
ing the work of Messersmith et al. (1995). Embryonic day 8 sympathetic
ganglia and embryonic day 7 dorsal root ganglia were dissected from
chick embryos. The explants were cocultured with aggregates of COS-7
cells secreting Sema6A-Fc, Sema6A-mh, SEMA3A-Fc, SEMA7A-Fc,
and mock Fc into the collagen bed. The cocultures were incubated at
37°C for 3 d in F12-based defined medium supplemented with bovine
pituitary extract and nerve growth factor (Luo et al., 1993) and were then
fixed and visualized by phase contrast on an inverted microscope. The
amounts of neurite outgrowth from sympathetics or DRGs in the prox-
imal and distal quadrants in relation to the COS cell aggregates were
compared and recorded. Positive chemorepulsive activity was scored
when the axons of the explants were not present in the proximal quad-
rants. The expression of semaphorins was confirmed by Western blot.
In situ hybridization. Embryos were obtained from time pregnant CF1
mice (Charles River Laboratories, Wilmington, MA). The plug date was
considered embryonic day 0. Pregnant females were killed by overdose of
sodium pentobarbital anesthesia, and embryos were extracted by cesar-
ean section and quickly frozen on dry ice in OCT embedding compound
(Tissue-Tek, Sakura). Cryostat sections (18–20 mM) were cut in horizon-
tal sections, thaw-mounted onto SuperFrost Plus slides (Fisher Scientific,
Houston, TX), and stored at 220°C. Slides with cryostat sections were
fixed, washed, acetylated, and dehydrated according to the protocol
described by Wright et al. (1995).
In situ hybridization was performed with plasmid SD89, containing a
340 bp fragment of Sema6A cDNA internal to the semaphorin domain
(Zhou et al., 1997). Plasmid SD89 was linearized to generate sense and
antisense probes with XhoI and NotI, respectively. Probes were gener-
ated by in vitro transcription with T7 (antisense) and T3 (sense) RNA
polymerases, in the presence of 33P-UTP (DuPont-NEN, Boston, MA).
Sections were hybridized with radiolabeled probe (10 6 cpm) overnight at
55°C in hybridization mixture as described previously (Wright et al.,
1995). On the following day, slides were washed with 43 SSC and treated
with RNase A (40 mg/ml; Boehringer Mannheim), rinsed with serial
dilutions of SSC, and dehydrated as described previously (Wright et al.,
1995). Sections were exposed to Kodak NTB-2 photographic emulsion
(Eastman Kodak, Rochester, NY) for 10 d. Slides were developed and
counterstained with hematoxylin and eosin as described previously
(Wright et al., 1995). Sections were viewed and photographed under dark
field with a Nikon (Tokyo, Japan) Eclipse microscope. Slide photographs
were scanned using Polaroid SprintScan 35 connected to Macintosh PC
9600 (Apple Computers, Cupertino, CA). Figures were generated with
brightness–contrast adjustments using Adobe Photoshop 5.0 software
(Adobe Systems, Mountain View, CA).
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RESULTS
Sema6A induces the collapse of sympathetic
growth cones
The potential chemorepulsive activity of secreted semaphorins
has been identified in growth cone collapse assays (Luo et al.,
1993). To determine the activity of the transmembrane protein
Sema6A, we have engineered two soluble versions of Sema6A,
Sema6A-mh and Sema6A-Fc, by fusing the extracellular domain
of Sema6A with either a Myc-His tag or an Fc domain of human
IgG1 at the COOH terminus, respectively. Sema6A-mh and
Sema6A-Fc were highly expressed in mammalian cells, and they
can be detected by either an anti-myc or an anti-Fc antibody (data
not shown). Supernatants collected from HEK 293 cells trans-
fected with these fusion constructs were used as sources for
soluble fusion proteins. Sema6A-Fc supernatant collapsed sym-
pathetic, but not dorsal root ganglion (DRG), growth cones (Fig.
1A,B). In comparison, SEMA3A-Fc collapsed, in a similar man-
ner, both sympathetic and DRG growth cones. As a control, Fc
domain alone showed no appreciable amount of collapsing activ-
ity (Fig. 1A,B) (Eickholt et al., 1997).
To quantify the activity of Sema6A, Sema6A-mh and
Sema6A-Fc were purified to purity ;50% through affinity chro-
matography and tested on chick sympathetic and DRG explants
in the growth cone collapse assay. The collapsing activity of
Sema6A-Fc and SEMA3A is dose-dependent. Sema6A-Fc in-
duces the collapse of 50% of sympathetic growth cones at a
concentration ;200 pM, which is ;200-fold less potent than
partially purified SEMA3A produced in baculovirus (Fig. 1C).
To determine whether Sema6A-Fc is active toward sympathet-
ics of other species and whether the activity shows any rostrocau-
dal polarity, we have also tested the growth cone collapse activity
of Sema6A-Fc on mouse thoracic and superior cervical sympa-
thetic ganglia. Sema6A-Fc collapses growth cones of both mouse
thoracic and superior cervical sympathetic neurons (data not
shown).
Sema6A-Fc collapses sensory growth cones at a
concentration 10-fold higher than for sympathetics
Although Sema6A-Fc supernatants and concentrations of puri-
fied Sema6A-Fc up to 300 pM showed no effect on DRG growth
cones, higher concentrations of Sema6A-Fc collapsed DRG
growth cones (Fig. 2). DRG explants cultured in either NGF or
neurotrophin-3 (NT-3) were treated with doses of 0.3, 1.0, or 3.0
nM Sema6A-Fc. These two neurotrophins support the survival of
the two major populations of early embryonic DRG neurons
in vitro (Hory-Lee at al., 1993; Messersmith et al., 1995).
Unlike sympathetic neurons, which showed a half-maximal
concentration for growth cone collapse by Sema6A-Fc at ;200
pM (Fig. 1C), DRG neurons showed no response to 300 pM
(0.3 nM) Sema6A-Fc (Fig. 2A,B). In contrast, both NGF-sensitive
Figure 1. Sema6A collapses sympa-
thetic but not DRG growth cones. A,
Sema6A collapses chick sympathetic
growth cones. Sympathetic ganglion de-
rived from E8 and DRG derived from
E7 chick embryos were cultured with
25 ng/ml NGF on plates precoated
with poly-ornithine and mouse lam-
inin for 20 hr and then were incubated
with purified Sema6A-Fc (;0.6 nM)
and conditioned medium containing
SEMA3A-Fc (;0.1 nM) for 1 hr. Cul-
tures were then fixed and visualized
with rhodamine phalloidin. Condi-
tioned medium containing mock Fc was
used as a negative control. Scale bar, 25
mm. B, The relative responsiveness of
chick sympathetic and DRG growth
cones to Sema6A-Fc, SEMA3A-Fc, and
Mock Fc as done in A was plotted as the
percentage of collapsed growth cones.
Sema6A-Fc (;0.6 nM) collapses chick
sympathetic but not DRG growth
cones. SEMA3A-Fc (;0.1 nM) col-
lapses both sympathetic and DRG
growth cones, whereas mock Fc shows
no collapsing activity. SD is included.
C, Dose–response curve comparing the
growth cone collapsing activities of pu-
rified Sema6A-Fc, Sema6A-mh, and
SEMA3A. The percentage of collapsed
chick sympathetic growth cones is plot-
ted against the concentration of puri-
fied proteins displayed on a logarithmic
scale with SD. The concentration of
purified proteins was estimated by com-
paring the intensity of Coomassie Blue
stain in SDS-PAGE gel using BSA as
standard.
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and NT-3-sensitive DRG neurons showed progressively greater
percentages of collapsed growth cones at 1.0 and 3.0 nM
Sema6A-Fc (Fig. 2B,C). Both populations of DRG neurons show
approximately the same sensitivity to Sema6A-Fc but are ;10-fold
less sensitive than sympathetic neurons; a half-maximal growth
cone collapse effect is predicted at ;2 nM Sema6A-Fc for DRG,
which is exactly 10-fold higher than for sympathetics (Fig. 2C).
E7 and E10 chick DRG neurons showed differential response
to Sema3A when cultured in NT-3-supplemented media (Shep-
herd et al., 1997). We have therefore tested the activity of
Sema6A-Fc on DRG neurons from these two stages. Both E7 and
E10 DRG growth cones were collapsed in response to a higher
concentration of Sema6a-Fc (3 nM), whether they are grown in
NGF or NT-3-supplemented media (data not shown).
Sema6A collapsing activity is dimerization-dependent
Secreted semaphorins, such as SEMA3A, are known to form
homodimers and the dimerization is required for activity (Klos-
termann et al., 1998; Koppel and Raper, 1998). To determine
whether the activity of transmembrane protein Sema6A is depen-
dent on protein dimerization or oligomerization, we have com-
pared the activity of Sema6A-mh and Sema6A-Fc. When run
under nonreducing conditions by SDS-PAGE gel, Sema6A-Fc
migrates at a size approximately twice that when run in a reduc-
ing condition (Fig. 3A). In contrast, the size of Sema6A-mh does
not change when run in either reducing or nonreducing condi-
tions. This result suggests that Sema6A-Fc behaves like a dimer
linked by disulfide bonds, whereas Sema6A-mh exists as a mono-
mer. Whereas the dimeric Sema6A-Fc induces the collapse of
sympathetic growth cones in a dose-dependent manner, the mo-
nomeric Sema6A-mh does not exhibit collapsing activity at the
tested concentrations (Fig. 1C). The Myc-His-tagged Sema6A
was expressed as a soluble recombinant protein like the other
semaphorins, and it was purified through very mild binding and
elution conditions. So it is unlikely that the lack of collapsing
Figure 2. High concentrations of
Sema6A-Fc collapse DRG, as well as sym-
pathetic growth cones. A, Sema6A-Fc can
collapse growth cones of two distinct
DRG neuron populations, as well as
sympathetics. Panels from lef t to right
show growth cones from mouse E15 cul-
ture of sympathetic ganglia in 25 ng/ml
NGF (lef t), dorsal root ganglia cultured
in 25 ng/ml NGF (center), and dorsal
root ganglia cultured in 25 ng/ml NT-3
(right). Axons and growth cones are spe-
cifically labeled with anti-GAP-43. Con-
centrations of Sema6A-Fc corresponding
to each image are shown in the bottom
right corner of each image. Arrows indi-
cate examples of intact growth cones for
each neuronal population. Sympathetic
growth cones are collapsed by treatment
with 0.3 nM Sema6A-Fc but not by treat-
ment with 0.1 nM Sema6A-Fc. Treat-
ment with 0.3 nM Sema6A-Fc fails to
collapse growth cones of either NGF- or
NT-3-sensitive DRG neurons; however,
treatment with 3nM Sema6A-Fc col-
lapses growth cones for both of these pop-
ulations. Note that large, lamellopodial-
shaped growth cones indicated in the
top right panel are typical of the partic-
ular NT-3-dependent murine embryonic
DRG neurons. Scale bar, 25 mm. B,
Growth cone collapse of E8 chick sym-
pathetic and E7 DRG neurons. E8 chick
sympathetic or E7 DRG explants were
cultured, as were mouse ganglia in A
and C. Bars show percentage of col-
lapsed growth cones with SD after treat-
ment with 0.3, 1, or 3 nM partially puri-
fied Sema6A-Fc. Sympathetic growth
cones show ;80% growth cone collapse
by 0. 3 nM Sema6A-Fc, whereas compa-
rable growth cone collapse is not ob-
served for either sensory population be-
low 3 nM Sema6A-Fc. C, Dose–response
curves for mouse E15 growth cone col-
lapse by purified Sema6A-Fc. Percent of
collapsed growth cones is shown with
SD for sympathetics and DRG explants
cultured in either NGF or NT-3 as in A. A half-maximal growth cone collapse response to Sema6A-Fc is observed at ;0.2 nM (200 pM) Sema6A-Fc for
sympathetics. For both DRG populations, half-maximal effect is observed at ;2 nM Sema6A-Fc, or 10-fold higher than for sympathetics. Mouse DRG
axons in NT-3, unlike other populations assayed, exhibit ;40% collapsed growth cones at baseline (also observed with vehicle; data not shown), whereas
for other populations the baseline is below 20%.
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activity of Sema6A is attributable to the denaturation occurred
during protein expression and purification. Rather, Sema6A may
require dimerization or oligomerization to be active. It is worth
noting that a PDZ (postsynaptic density 95/discs large/zona
occludens-1) protein, SEMCAP-1, was shown to induce the ag-
gregation of transmembrane protein Sema5A (M-SemF) through
its interaction with the intracellular domain of Sema5A (L.H.
Wang et al., 1999). Sema6A may use a similar mechanism to
regulate its activity.
Sema6A repels sympathetic axons
Because the repulsive activity of secreted semaphorins has been
tested in chemorepulsion assays (Messersmith et al., 1995), we
have determined the activity of Sema6A by coculturing chick E8
sympathetic or E7 DRG explants with aggregates of COS cells
transfected with either Sema6A-Fc or Sema6A-mh. Sema6A-Fc
secreted from COS cell aggregates dramatically reduced the
amount of axon outgrowth from the proximal side of the sympa-
thetic explants, but no effect was seen on DRG explants (Fig.
4A,C). In comparison, SEMA3A-Fc had a repulsive effect on
both sympathetic and DRG explants (Fig. 4A,C). No repulsive
effect was observed when mock Fc (data not shown) or
SEMA7A-Fc were transfected to COS cell aggregates (Xu et al.,
1998). In addition, full-length transmembrane Sema6A showed
no repulsive activity toward sympathetic axons in this assay when
the COS cell aggregates were not in contact with the sympathetic
axons.
Interestingly, Sema6A-mh also exhibited a significant amount
of repulsive activity toward sympathetic axons, albeit at a much
lower potency than Sema6A-Fc (Fig. 4C). It is possible that
collagen matrix used in this assay may contain components that
promote the dimerization or oligomerization of Sema6A-mh.
Alternatively, Sema6A-mh may be active in this particular sensi-
tive assay system.
We did not observe any effect of Sema6A-Fc on DRG axons in
this system, suggesting that the COS cells could not secrete
sufficient Sema6A-Fc into the collagen gel to reach a high enough
concentration in the gel that would affect DRG axons. As sug-
gested by dose–response experiments with sympathetic and DRG
growth cones (Figs. 1C, 2B,C), the maximal concentration of
Sema6A-Fc in collagen gels may fall in the window between a
dose affecting sympathetic axons and a dose affecting DRG
axons.
In addition to the chemorepulsive effect we observed on
SEMA3A-Fc, we also found that, when sympathetic explants
were cocultured with SEMA3A-Fc-expressing COS cells, no sym-
pathetic axons were grown from the majority of the sympathetic
explants tested. It is not clear whether this effect is caused by the
death of sympathetic neurons or by the inhibition of sympathetic
axon outgrowth. Nonetheless, it suggests that SEMA3A may have
as yet uncharacterized biological activity on neurons.
Sema6A expression in development suggests roles in
sympathetic axon guidance in vivo
Sema6A expression was analyzed by in situ mRNA hybridization
to determine whether the topographic expression of this molecule
is suggestive of a role in embryonic sympathetic axon guidance.
Previously published in situ hybridization data for Sema6A fo-
cused on its expression in CNS but also have shown it is expressed
in the early mouse embryo and particularly in ventral neural tube,
from E11 (Zhou et al., 1997). At E12, expression of Sema6A
mRNA shows an expression pattern similar to that observed for
Sema3A (Wright et al., 1995; Adams et al., 1996; Puschel et al.,
1996). Sema6A, like Sema3A, is expressed throughout the
somites and in the ventral spinal cord (Fig. 5A,B). Unlike
Sema3A and spinal cord-expressed Sema3B (SemA), Sema4A
(SemB), Sema3C (SemE), Sema5A (SemF), and Sema5B (SemG)
(Adams et al., 1996; Puschel et al., 1996), it is also expressed in
the DRG (Fig. 5, asterisks). Sema6A is likewise expressed in the
gastrointestinal tract and its mesenteries (Fig. 5A,B).
At E13, Sema6A is expressed in a large assortment of devel-
oping tissues in the thoracic and abdominal regions (Fig. 5C–F).
In addition to DRG and spinal cord, these include the gastroin-
testinal tract (Fig. 5E,F) and kidneys (Fig. 5F), and skeletal
muscle throughout the embryo (Fig. 5E,F, Dia Ps).
Sema6A is not expressed in the sympathetic ganglion chains,
which are visible by E12 (Fig. 5A,B, arrowheads) and more
noticeable at E13 (Fig. 5C–F, and especially G, arrowheads).
Notably, a ring of Sema6A-expressing tissue is observed encir-
cling the sympathetic chains, which themselves do not express
Sema6A (Fig. 5C,D,G). This particular expression pattern is
observable from E12 throughout embryonic development (data
Figure 3. Sema6A collapsing activity is dimerization-dependent. A, Dimerization of Sema6A. Sema6A-mh and Sema6A-Fc fusion proteins were run
on a 4–20% SDS-polyacrylamide gel under both reducing (R) (sample buffer with 10% BMEM) and nonreducing conditions (NR) (sample buffer without
BMEM) and visualized on Western blots with a monoclonal antibody against the Myc tag and a monoclonal antibody against the Fc tag. The expected
molecular weight for Sema6A-mh monomer is 100 kDa, and Sema6A-Fc is 150 kDa. B, Dimeric Sema6A-Fc induces the collapse of chick sympathetic
growth cones. Sympathetic ganglion derived from E8 chick embryos were cultured as in Figure 1A and incubated with purified Sema6A-mh and
Sema6A-Fc for 1 hr before fixation and visualization with rhodamine phalloidin. Mock Fc was tested as a negative control. Scale bar, 25 mm.
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not shown for ages after E15). At these ages, when the sympa-
thetic chains are in their early development, the expression of
Sema6A around the sympathetic chain is most noticeable in the
thoracic region, from the inferior cervical–first thoracic sympa-
thetic ganglion level (Fig. 5C, arrowheads) to midthoracic ganglia
(Fig. 5D,G).
Sema6A expression is absent in cervical, as well as thoracic,
sympathetic ganglia (Fig. 6A, SCG). In contrast, the glossopha-
ryngeal ganglia and cochlea (Fig. 6B), immediately superior to
the superior cervical ganglia (Fig. 6A), show a high level of
Sema6A mRNA labeling. Additionally, skeletal muscles in the
vicinity of cervical and thoracic sympathetic ganglia (Fig. 6A,B)
strongly express Sema6A. Sema6A is also expressed in the eye
and optic nerve (Fig. 6C, arrowheads denote optic nerve), as well
as the olfactory epithelium and other nonsympathetic cranial
ganglia (data not shown). Consequentially, we hypothesize that
Sema6A prevents the sympathetic innervation of nonsympathetic
neural tissues in physical proximity to the peripheral nervous
system.
Sema6A expression in non-neural tissues is most widespread
during the early stages of embryonic development, from E12
through E15. From E15, there begins a period of substantial
downregulation of Sema6A message in several tissues. From E15
to E16, there is a dramatic loss of detectable Sema6A message
signal from the lung (Fig. 7A,B). Sema6A message is likewise
reduced in skeletal muscle (Fig. 7, compare B,D with A,C), DRG
(Fig. 7C,D), and abdominal mesenteries (Fig. 7C,D), between
E15 and E16. Indeed, at E16, the only evident sites of expression
of Sema6A in the thorax and abdomen are the spinal cord,
excluding the dorsal horn (Fig. 7A–D), and the epithelium of the
small intestine (Fig. 6D,E).
DISCUSSION
Sema6A, a transmembrane semaphorin, is
chemorepulsive for sympathetic neurons
Since the identification of semaphorins as a large family of po-
tential axon guidance molecules, it has become an evident ques-
tion whether these molecules function overwhelmingly as axonal
chemorepellents versus occupying other roles in development. A
systematic screen to identify novel activities of semaphorins on
embryonic axons originally showed soluble Sema6A fusion pro-
teins to be active growth cone collapse agents for embryonic chick
sympathetic neurons, but not DRG neurons. This activity was
confirmed by means of the collagen matrix chemorepulsion assay.
At higher concentrations, soluble Sema6A fusion proteins were
shown to collapse DRG growth cones, as well as sympathetic
growth cones. Both NGF and NT-3 responsive populations re-
sponded at these higher concentrations.
These results demonstrate the principle that membrane-bound
semaphorins may act as chemoinhibitory molecules in vertebrate
nervous system development: a role similar to and likely overlap-
ping with that of the class 3 semaphorins. Before this study,
chemorepulsive or chemoattractive roles have been reported for
several vertebrate class 3 semaphorins, but not for any of the
identified vertebrate transmembrane semaphorins. While our
Figure 4. Sema6A repels chick sympa-
thetic but not DRG axons. A, Sema6A
repels chick sympathetic axons. E8 chick
sympathetic and E7 chick DRG explants
were cocultured for 72 hr at a distance
from aggregates of COS-7 cells (lef t)
secreting Sema6A-Fc or SEMA3A-Fc in
collagen matrix gels in medium contain-
ing 25 ng/ml NGF. Sympathetic but
not DRG axons in the proximal side
are repelled by aggregates of COS-7
cells secreting Sema6A-Fc. Both sym-
pathetic and DRG axons are repelled
by aggregates of COS-7 cells secreting
SEMA3A-Fc. Scale bar, 0.1 mm. B,
Schematic representation of the method
used to quantify chemorepulsion. The
field surrounding each of DRG or sym-
pathetic explants is divided into four
quadrants. The amount of neurite out-
growth in the proximal (P), lateral (L),
and distal (D) quadrants relative to the
semaphorin expressing COS-7 cells was
measured. Because of the strong che-
morepulsive effect observed in our cul-
ture system, the repulsive activity was
scored as 1 when the neurite outgrowth
is present only in the distal quadrant, 0.5
when present in both lateral and distal
quadrants, and 0 when present in all
quadrants. The analysis was done when
axonal tips were not directly in contact
with COS-7 cells, therefore excluding
any direct contact-mediated effects. C,
The relative chemorepulsive activity of
semaphorins was compared based on
the quantitative method specified in B.
The height of the bar represents the average score of the tested samples. Two-sample t test assuming unequal variance was used to determine the
statistical significance. Both Sema6A-Fc (n 5 18) and Sema6A-mh (n 5 14) showed statistically significant chemorepulsive effect toward sympathetic
axons when compared with SEMA7A-Fc (n 5 14), with p , 0.0001 and p , 0.005, respectively.
Xu et al. • Sema6A Repels Sympathetic Axons J. Neurosci., April 1, 2000, 20(7):2638–2648 2643
Figure 5. Expression of murine Sema6A mRNA in early development (E12–E13). Radiolabeled in situ hybridization shows sites of Sema6A mRNA
expression in horizontal sections of mouse embryos at E12 (A, B) and E13 ( C–G). Sections through E12 embryos at midthoracic (A) and upper
abdominal (B) levels show Sema6A mRNA expression in the somites (dotted outline), limb buds, ventral portions of the spinal cord (SC), dorsal root
ganglia (asterisks), and the gastrointestinal tract and its mesenteries (GI ). Sema6A is not expressed in the heart or liver, as shown. At both E12 (A, B)
and E13 (C–G), Sema6A mRNA is excluded from the sites of the sympathetic chains (small arrowheads in A–G) but is consistently expressed in dorsal
root ganglia (asterisks, A–G) and the ventral portions of the spinal cord (SC, A–G). At E13, Sema6A expression is shown at the following levels: lower
cervical ( C), midthoracic (D, including forelimb, and high power of sympathetic ganglia in G), upper abdominal (E), and lower abdominal (F, including
hindlimb). Sema6A mRNA is not expressed in the heart (D) or liver (E). It is strongly expressed in the skeletal muscles, (Figure legend continues)
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work was being prepared for publication, another member of class
6 semaphorin, Sema6C (Sema Y), was reported to collapse so-
meof the sensory growth cones (Kikuchi et al., 1999). This
molecule is closely homologous to Sema6A, suggesting multiple
class 6 semaphorins are likely to have activities similar to class 3
semaphorins.
We have observed that Sema6A is 200-fold less active than
SEMA3A in the growth cone collapse assay. We do not know the
reason for this sensitivity difference. One possibility is that a
functionally relevant transmembrane semaphorin is not required
to be as active as a secreted semaphorin because it is localized on
the cell surface and therefore it may have a high effective con-
centration. Alternatively, the Fc-tagged soluble Sema6A is not
fully active compared with the transmembrane Sema6A.
The dimerization requirement for Sema6A suggests a
common mechanism of semaphorin function
Whereas the dimeric fusion protein Sema6A-Fc collapsed and
repelled sympathetic growth cones, the monomeric Sema6A-mh
fusion protein was not comparably active in these assays. This
suggests class 6 semaphorins are active as dimers or oligomers,
similar to what has been observed for class 3 semaphorins (Klos-
termann et al., 1998; Koppel and Raper, 1998). Despite this
common feature, Sema6A does not bind to either neuropilin-1 or
neuropilin-2, the identified receptor components for class 3 sema-
phorins (Chen et al., 1997) (X. Xu and Y. Luo, unpublished
observation). Instead, receptors for Sema6A and other class 6
semaphorins are likely to be plexins, a family of molecules con-
served from insects to vertebrates (Kameyama et al., 1996; Mae-
strini et al., 1996; Fujisawa et al., 1997; Comeau et al., 1998,
Winberg et al., 1998). It has been shown that VESPR, a member
of plexin family, is a receptor for a vaccinia virus semaphorin, and
that Drosophila Plexin A is a functional receptor mediating the
axon guidance function of Drosophila Sema-1a. A recently pub-
lished study has shown that a large, multiclass family of plexins
exists, with each class of plexins potentially comprising receptor
components for a particular class of semaphorins (Tamagnone et
al., 1999). Based on our results and those of recent studies, it
appears likely that the receptors for class 6 semaphorins include
a class A plexin component, as do the receptors for class 3
semaphorins (Takahashi et al., 1999; Tamagnone et al., 1999).
Sema6A expression suggests an inhibitory axon
guidance function on sympathetic neurons
The case for Sema6A as a chemoinhibitory factor is clearest with
respect to sympathetics. Sema6A is strikingly absent from sym-
pathetic ganglia. Furthermore, developing sympathetic axons
must avoid tissues such as skeletal muscle, sensory ganglia, and
optic nerve, which express Sema6A. We have also observed that
Sema6A is expressed in a ringing pattern in the surrounding
sheath of the sympathetic chain (as in Fig. 5G), suggesting a role
for Sema6A in restricting the longitudinal course of axons form-
ing the sympathetic chains, preventing them from extending pro-
jections outside the chains except at the specific exit points of the
white rami communicantes. Sema6A is not expressed in the
sympathetic chains themselves or in sympathetic target tissues,
such as the heart and blood vessels.
Repulsion of embryonic chick sympathetic axons from mem-
brane fractions derived from lung and skeletal muscle, tissues that
express Sema6A, has been observed previously in a stripe assay
(Kuromi, 1992). In earlier studies, DRG and sympathetic axons
were shown to avoid retinal axons when DRG or sympathetic
explants are cocultured with retinal explants (Bray et al., 1980;
Kapfhammer and Raper, 1987b). In fact, growth cone collapse
was first observed in the encounter of sympathetic growth cones
with retinal axons (Kapfhammer and Raper, 1987a). It has been
suggested that retinal axons contain a central label that can
induce the collapse of sympathetic growth cones. Yet the molec-
ular identity of such a signal has not been identified. The activity
and expression profiles of Sema6A fit the trait of this long sought
guidance signal.
It is also notable that Sema6A is expressed in the embryonic
lung and gastrointestinal tract. The lung and gastrointestinal tract
contain their own neuronal plexi, which are distinct from the
parasympathetic and sympathetic systems. These tissues are not
innervated by sympathetic axons while they express Sema6A.
Sema6A expression in these tissues, however, is downregulated
from E15 to E16, but this downregulation is not immediately
followed by sympathetic axon penetration. Sympathetic axons are
absent from the lungs throughout embryonic development, their
extrinsic innervation in utero being predominantly parasympa-
thetic (Sparrow and Weichselbaum, 1997). Likewise, extrinsic
sympathetic innervation of the myenteric and submucosal plexi of
the bowel was observed to develop in the early postnatal period in
rats (Hill and Ngu, 1987). It is likely that, after the rapid down-
regulation of Sema6A message in lung, skeletal muscle, and
mesenteries occurring at E15–E16, the inhibitory role continues
to be occupied by some other molecule(s). This appears particu-
larly likely because the soluble semaphorin Sema3F (formerly
named Sema IV), which, like Sema6A, can repel sympathetic
axons, is expressed in both the lung and the gastrointestinal tract
after Sema6A expression has been downregulated in these vis-
cera (Giger et al., 1998).
Sema6A activity on sensory versus sympathetic
neurons may correspond to distinct roles in vivo
More perplexing is the issue that Sema6A is expressed in both
dorsal root ganglia and tissues such as muscle and dermis, which
they innervate. Because Sema6A was observed to collapse the
growth cones of dorsal root ganglion axons, albeit at a 10-fold
higher concentration than that affecting sympathetics, it is more
difficult to conclude whether Sema6A acts as a chemorepellent for
DRG axons in vivo. The expression pattern of Sema6A overlaps
with that of Sema3A, which repels both sensory and sympathetic
neurons, in sites such as early somites, skeletal muscles, and
ventral spinal cord. A weak sensitivity of DRG neurons to
Sema6A may help explain why, in Sema3A null mice, although
invasion of these areas by sensory neurons is observed, it is not
total, and a sizable proportion of the sensory populations appear
to maintain the wild-type trajectory (Taniguchi et al., 1997).
Nonetheless, the presence of Sema6A in both dorsal root ganglia
and target tissues suggests a different role from that for
sympathetics.
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including diaphragm (E, Dia) and psoas (F, Ps). It is also expressed in the gastrointestinal tract, including duodenum (E, Duod), stomach (F, Sto), and
intestinal loops including herniations present at this age (GI in E, F ). Expression is also observed in the inferior poles of the lungs (E, arrows) and the
kidneys (K in F ). G is a high-power view of D showing Sema6A mRNA excluded from the sympathetic ganglia but present in the surrounding sheath
(arrowheads) and in dorsal root ganglia (asterisks). Scale bars, 0.5 mm.
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Several plexins are also expressed by DRG neurons, as well as
by sympathetics (Takahashi et al., 1999; Tamagnone et al., 1999),
but whether receptor differences can explain the differences in
sensitivity is unclear. Sema6A in sensory ganglia may serve a
Figure 6. Expression of Sema6A mRNA in cranial tissues avoided by
sympathetic axons. A, Sema6A expression at E14 at the level of the
superior cervical ganglia (SCG). Sema6A is not expressed in superior
cervical ganglia (also surrounded by dotted outline). Sema6A is expressed,
however, in the adjacent skeletal muscles (Musc, long arrows), as well as
dorsal root ganglia (DRG) and cervical spinal cord (SC). VB denotes the
vertebral body. B, Sema6A expression at the level of the glossopharyngeal
ganglia, directly superior to the superior cervical ganglia. Sema6A is
strongly expressed in the glossopharyngeal ganglia (short arrows, IXg) and
cochlea (Co), as well as skeletal muscles (Musc). C, Sema6A expression at
E15 at the level of the optic chiasm. Sema6A is expressed in the trigeminal
ganglia (Vg), eyes (specifically retinal ganglion cell layer; the intense
Figure 7. Visceral Sema6A expression altered from E15 to E16. Expres-
sion of Sema6A mRNA is shown at E15 (A, C) and E16 (B, D, E).
Sema6A is highly expressed in the lung and in thoracic skeletal muscle at
E15 (A) but is downregulated in these tissues by E16 (B). In contrast,
Sema6A expression in the spinal cord (SC) remains high. At E15, Sema6A
is also expressed in multiple abdominal locations (C), including the
stomach (Sto) and intestines (GI ), but not the bladder (Bl ). It is also
highly expressed in skeletal muscle (Musc), including diaphragm (Dia). At
E16 ( D), in contrast, Sema6A mRNA is no longer observed in the wall of
the stomach (Sto) or in mesenteries of the gastrointestinal tract. It is still
expressed at a high level in spinal cord (SC) but appears downregulated
in muscle. A high-power view of the intestine at E16 (E) shows that the
high level of signal in the intestine at this age is confined to the epithe-
lium. Scale bars: A–D, 0.5 mm; E, 0.1 mm.
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labeling of the sclera may be artifactual), and optic nerves (arrowheads,
ON ). Although it is not expressed in the optic chiasm, it is expressed in
the hypothalamus (Hyp). It is also excluded from the nasal epithelium
(NE). E14–E15, Horizontal sections. Scale bars, 0.5 mm.
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function other than chemorepulsion, such as an inhibition of axon
branching within the sensory ganglia themselves. Notably, dual
functions on axon guidance and branching on distinct neuronal
populations have been observed for the slit family molecule Slit2
(Ba-Charvet et al., 1999; Brose et al., 1999; Li et al., 1999; K.H.
Wang et al., 1999) (for review, see Zinn and Sun, 1999). Alter-
natively, Sema6A could be a chemorepellent for both classes of
axons in vivo. The example is not without precedent: motor
neurons can be repelled by Sema3A, which is expressed in the
ventral spinal cord (Varela-Echavarria et al., 1997).
Multiple molecules are likely to direct guidance of
PNS axons
In our initial description of the cloning and expression of
Sema6A, we hypothesized that multiple semaphorins would con-
tribute to a complex addressing system directing particular axons
to their targets by means of selective chemorepulsion or growth
restriction (Zhou et al., 1997). The activity we have now observed
for Sema6A on sympathetic axons, and Sema6A expression in
tissues that must be avoided by these axons in development, are
findings consistent with this hypothesis.
Several of the class 3 semaphorins, including SEMA3A, have
also been shown to be repulsive for sympathetic axons (Chen et
al., 1998; Giger et al., 1998; Klostermann et al., 1998). Mice
lacking expression of Sema3A or neuropilin-1 do not have signif-
icant abnormalities of sympathetic chain structure (Kitsukawa et
al., 1997; Taniguchi et al., 1997). In retrospect, this is consistent
with the activity of Sema6A and localization around the sympa-
thetic chains. Additionally, many of the sites of Sema6A expres-
sion in development are also sites of expression of other sema-
phorins and of other nonsemaphorin axon inhibitors, such as slit
(Brose et al., 1999; Li et al., 1999; K.H. Wang et al., 1999). Among
the class 3 semaphorins that have been shown previously to repel
sympathetic axons, several are expressed at sites at which they
could complement with Sema6A in preventing sympathetic axon
ingrowth. As examples, Sema3A is expressed in the sheath of the
optic nerve (Zhou et al., 1997), and Sema3F shows expression
similar to or overlapping with that of Sema6A in kidney, lung, and
the gastrointestinal tract (Giger et al., 1998). So it is likely that
many of these overlapping molecules have redundant functions
acting on any one class of axons, but that precise combinations of
them may guide many classes of axons, by process of elimination,
to their target tissues.
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